MBIO 润色咨询

mBio

出版年份：2010 年文章数：5460 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：4.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2024-04-13 ms7000000797363888 来自浙江省

    1

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2023-12-19 Descuenxk 来自德国

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：病毒学
    经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2023-05-17 ms5000000232706336 来自丹麦

    偏重的研究方向：微生物
    经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2020-12-22 wnj1738555_28787312

    审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0
    偏重的研究方向：医学;病毒
    经验分享：mbio的质量距离plos pathogens还是有差距的
    别听这个版上的无脑喷子的话
    去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS
    mbio好像一篇都没有

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2020-03-12 Biomed2015

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。

    @180****3363

    一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2021-11-08 Zchi

    初投21天，要求修改后重投，然后修了一个月，再投5天后接受，
    mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！

    9

    展开9条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2023-02-04 ms2000001468453392 来自浙江省

    在投

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2022-12-18 ms9000001911772190 来自广东省

    偏重的研究方向：天然免疫
    经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2020-05-09 1dde6fb5m72(暂无匿称)

    请问投稿后第二天就decision pending,是不是要被拒稿？

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2137200, encodeId=ab41213e200e8, content=偏重的研究方向：微生物<br>经验分享：请问大家，Mbio和microbiome哪个好？如果环境微生物方向投稿，先试哪个杂志合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a48688785, createdName=ms5000000232706336, createdTime=Wed May 17 21:14:59 CST 2023, time=2023-05-17, status=1, ipAttribution=丹麦), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586441, encodeId=0f7e586441bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：我也遇到被拒到但是允许重投的情况，着急中。。。 <br> <br> @180****3363 <br> <br> 一审一个月左右，据稿让重投就还有希望。修改花了1个月，重投后1月小修标明基本接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c461630680, createdName=Biomed2015, createdTime=Thu Mar 12 09:51:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068087, encodeId=5b6e106808e28, content=初投21天，要求修改后重投，然后修了一个月，再投5天后接受，<br>mBio，是微生物领域顶级期刊，IF也算高的。推荐！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bd71741987, createdName=Zchi, createdTime=Mon Nov 08 12:17:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590501, encodeId=e243590501bc, content=请问投稿后第二天就decision pending,是不是要被拒稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XSnxM4uP67librN3OZmlDZnCr8vvf2sEvxo2DVNFjyw7kg7lwh6omHcibzNibkuuicZugvCm8tRZUvePnhygJwqeNw/132, createdBy=d39a1659584, createdName=1dde6fb5m72(暂无匿称), createdTime=Sat May 09 11:12:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=)]
    2022-08-30 ms6000000949743620

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：病毒;微生物
    经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了

    0

共103条页码: 1/11页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分